These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15328120)

  • 1. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.
    Shih SR; Tsai MC; Tseng SN; Won KF; Shia KS; Li WT; Chern JH; Chen GW; Lee CC; Lee YC; Peng KC; Chao YS
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3523-9. PubMed ID: 15328120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants.
    Chen TC; Liu SC; Huang PN; Chang HY; Chern JH; Shih SR
    J Biomed Sci; 2008 May; 15(3):291-300. PubMed ID: 18196474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors.
    Shia KS; Li WT; Chang CM; Hsu MC; Chern JH; Leong MK; Tseng SN; Lee CC; Lee YC; Chen SJ; Peng KC; Tseng HY; Chang YL; Tai CL; Shih SR
    J Med Chem; 2002 Apr; 45(8):1644-55. PubMed ID: 11931618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.
    Yuan S; Li G; Wang Y; Gao Q; Wang Y; Cui R; Altmeyer R; Zou G
    J Virol; 2016 Jan; 90(2):741-52. PubMed ID: 26512078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
    Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
    Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazolidinones and Imidazolidine-2,4-diones as Antiviral Agents.
    Swain SP; Mohanty S
    ChemMedChem; 2019 Feb; 14(3):291-302. PubMed ID: 30600644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
    Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
    Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
    Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
    Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
    Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
    J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
    Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
    Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
    Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
    J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
    Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
    PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain).
    Victorio CB; Xu Y; Ng Q; Meng T; Chow VT; Chua KB
    Emerg Microbes Infect; 2016 Jun; 5(6):e60. PubMed ID: 27329847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.
    Liu HM; Roberts JA; Moore D; Anderson B; Pallansch MA; Pevear DC; Collett MS; Oberste MS
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5568-74. PubMed ID: 22890765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
    Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
    Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
    Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection.
    Arita M; Takebe Y; Wakita T; Shimizu H
    J Gen Virol; 2010 Nov; 91(Pt 11):2734-44. PubMed ID: 20660150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
    Zaini Z; Phuektes P; McMinn P
    Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.
    Ren P; Zheng Y; Wang W; Hong L; Delpeyroux F; Arenzana-Seisdedos F; Altmeyer R
    Sci Rep; 2017 Feb; 7():42902. PubMed ID: 28218309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.